Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension

被引:38
作者
Assadi, Farahnak [1 ]
机构
[1] Rush Childrens Hosp, Chicago, IL 60612 USA
关键词
C-reactive protein; microalbuminuria; left ventricular hypertrophy; essential hypertension;
D O I
10.1007/s00246-007-9153-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microalbuminuria (MA) and C-reactive protein (CRP) levels are predictors of increased risk for left ventricular hypertrophy (LVH). Whether the strength of association between CRP and LVH is comparable to that of MA in hypertensive children is unknown. CRP and MA were measured in 64 children and adolescents with essential hypertension (HTN). In the entire population, CRP and MA showed positive relations with body mass index (BMI) (r = 0.30, p = 0.04 and r = 0.32, p = 0.04, respectively), systolic blood pressure (SBP) (r = 0.63, p = 0.03 and r = 0.58, p = 0.03, respectively), and LVH (r = 0.86, p < 0.001 and r = 0.81, p < 0.001, respectively). Patients with LVH (n = 23) had significantly higher BMI (p = 0.32), increased SBP (p = 0.031), and higher levels of CRP (p < 0.001) and MA (p < 0.001) compared with those without LVH. Multiple linear regression analysis demonstrated that CRP (r = 2.11, p < 0.001), MA (r = 1.94, p < 0.003), BMI (r = 0.53, p = 0.02), and SBP (r = 0.48, p = 0.04) were significantly associated with LVH. By analysis of covariance, CRP and MA were significantly different between patients who had LVH and those without LVH after adjustment for age, gender, BMI, SBP, SBP index, and diastolic blood pressure (p < 0.001 for the two markers). In conclusion, the strength of association between LVH and CRP is comparable to that of MA in children and adolescents with essential HTN.
引用
收藏
页码:580 / 584
页数:5
相关论文
共 32 条
[21]  
Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
[22]   Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version [J].
Ogden, CL ;
Kuczmarski, RJ ;
Flegal, KM ;
Mei, Z ;
Guo, S ;
Wei, R ;
Grummer-Strawn, LM ;
Curtin, LR ;
Roche, AF ;
Johnson, CL .
PEDIATRICS, 2002, 109 (01) :45-60
[23]   Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women [J].
Pannacciulli, N ;
Cantatore, FP ;
Minenna, A ;
Bellacicco, M ;
Giorgino, R ;
De Pergola, G .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (06) :502-507
[24]   Regression of left ventricular hypertrophy in children with antihypertensive therapy [J].
Ramaswamy, Prema ;
Lytrivi, Irene D. ;
Paul, Chikku ;
Golden, Mary ;
Kupferman, Juan C. .
PEDIATRIC NEPHROLOGY, 2007, 22 (01) :141-143
[25]   High-sensitivity C-reactive protein - Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [J].
Ridker, PM .
CIRCULATION, 2001, 103 (13) :1813-1818
[26]   C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [J].
Ridker, PM ;
Hennekens, CH ;
Buring, JE ;
Rifai, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (12) :836-843
[27]   C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study [J].
Rutter, MK ;
Meigs, JB ;
Sullivan, LM ;
D'Agostino, RB ;
Wilson, PWF .
CIRCULATION, 2004, 110 (04) :380-385
[28]  
SCHWARTZ GJ, 1976, PEDIATRICS, V106, P522
[29]   Carotid ultrasonography for detection of vascular abnormalities in hypertensive children [J].
Sorof, JM ;
Alexandrov, AV ;
Garami, Z ;
Turner, JL ;
Grafe, RE ;
Lai, DJ ;
Portman, RJ .
PEDIATRIC NEPHROLOGY, 2003, 18 (10) :1020-1024
[30]   C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease [J].
Stuveling, EM ;
Hillege, HL ;
Bakker, SJL ;
Asselbergs, FW ;
de Jong, PE ;
Gans, ROB ;
de Zeeuw, D .
ATHEROSCLEROSIS, 2004, 172 (01) :107-114